When was Transcell founded?

Transcell was founded in 2009 and raised its 1st funding round 6 years after it was founded.

Where is Transcell located?

Transcell is headquartered in Hyderabad, India. It is registered at 8th floor, Western pearl, Kondapur, Rangareddi, Hyderabad, Telangana, India, 500084.

Who is the current CEO of Transcell?

Subhadra Dravida of Transcell. They have also founded 1 company.

Which legal entities is Transcell associated with?

Transcell is associated with TRAN-SCELL BIOLOGICS PRIVATE LIMITED and 2 others.

How many employees does Transcell have?

As of May 31, 2026, the latest employee count at Transcell is 18.

Is Transcell a funded company?

Transcell is a funded company, having raised a total of $2.21M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 07, 2015.

How much is Transcell worth?

The latest valuation of Transcell is $***** as of Aug 09, 2024.

When was the latest funding round of Transcell?

Transcell's latest funding was a $***** Series A round on Jul 19, 2024, with participation from 4 investors.

What is the annual revenue of Transcell?

Annual revenue of Transcell is less than ₹10 Cr as on Mar 31, 2025

Where does Transcell rank among its competitors?

Transcell ranks 4th amongst 66 active competitors, of which 8 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Transcell, which secured $1.39M in Jul, 2024.

Who are the top competitors of Transcell?

Transcell's top competitors include Acorn, StemCyte and Cryo-Cell. Among them, Transcell secured the most recent funding round in July, 2024.

Transcell - 2026 Company Profile, Team, Funding, Competitors & Financials

Transcell is a series A company based in Hyderabad (India), founded in 2009. It operates as a Developer of stem cell therapies to treat cancer & rare diseases. Transcell has raised $2.21M in funding from Quantiphi and Indian Angel Network, with a current valuation of $*****. The company has 66 active competitors, including 8 funded and 9 that have exited. Its top competitors include companies like Acorn, StemCyte and Cryo-Cell.

Company Details

Transcell is a developer of stem cell therapies to treat cancer & rare diseases. It focused on the discovery and development of targeted Anti-cancer treatments, neurological ailments, and autoimmune disorders. The company has created a research and development ecosystem that creates a stem cell repository, develops cell-based platforms for both therapeutic and non-therapeutic applications. It provides regenerative medicine tools to treat debilitating diseases and delivers novel, patient-based, screening methods to discover druggable molecules.

Website: transcell.in/
Social
Email ID: *****@tran-scell.com
Phone Number: +91 **********
Registered Address: 8th floor, Western pearl, Kondapur, Rangareddi, Hyderabad, Telangana, India, 500084

Key Metrics

Founded Year

2009

Location

Hyderabad, India

Stage

Series A

Total Funding

$2.21M in 5 rounds

Latest Funding Round

Series A, Jul 19, 2024, $*****

Post Money Valuation

$***** as on Aug 09, 2024

Investors

Quantiphi & 82 more

Ranked

4^th among 66 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

18 as on May 31, 2026

Similar Companies

Acorn & 89 more

View Transcell's full profile

Transcell is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
TRANSCELL BIOLIFE PRIVATE LIMITED CIN: U74999TG2017PTC118697 , India, Amalgamated	Aug 03, 2017	0 - ₹10 Cr (As on Mar 31, 2023)	-
TRAN-SCELL BIOLOGICS PRIVATE LIMITED CIN: U85100TG2009PTC066172 , India, Active	Dec 07, 2009	0 - ₹10 Cr (As on Mar 31, 2025)	18 (As on Feb 28, 2025)
TRANSCELL BIOSCIENCES PRIVATE LIMITED CIN: U24290TG2022PTC162503 , India, Active	May 11, 2022	0 - ₹10 Cr (As on Mar 31, 2025)	-

Transcell has raised a total funding of $2.21M over 5 rounds. Its first funding round was on Nov 07, 2015. Its latest funding round was a Series A round on Jul 19, 2024 for $*****. 4 investors participated in its latest round. Transcell has 23 institutional investors and 60 angel investors.

Here is the list of recent funding rounds of Transcell:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 19, 2024	1558563	Series A	9073783	9960887	1062454	6896993
Dec 26, 2022	2562238	Seed	5096584	4016605	7021479	Rajasekhara Rao Mukkamala & 2 more
Apr 11, 2017	9480675	Seed	1672356	1212464	4673573	Nagendra P Bandaru & 55 more

Access funding benchmarks and valuations. Sign up today!

View details of Transcell's funding rounds and investors

Here are the details of Transcell's key team members:

Subhadra Dravida: Founder of Transcell.
Contact Info: 1 phone number

Transcell's Board of Directors

Transcell's board has 5 active members. Uday Chatterjee, Vinayender T Tulla, Raviprasad Pisupati and Subhadra Dravida are part of team and Asif Hasan is independent board member.

Here is the list of Transcell's board of directors:

Name	Type	Representing	Status	Duration
Raviprasad Pisupati	Team	-	Current	16y 7m
{vlxmph	Team	-	Past	9y 7m
zvkjs{e	Team	-	Past	1y 9m
ydezszm	Team	-	Past	6y 2m
vhitc{r	Team	-	Past	4y 2m
Uday Chatterjee	Investor	-	Current	6y 2m
Vinayender T Tulla	Investor	-	Current	10y 9m
geiuopw	Investor	mzpqquy	Past	8y 3m
Asif Hasan	Independent board member	-	Current	2y 0m
dzka{xe	Independent board member	-	Past	7y 7m
chfoxnv	Independent board member	-	Past	3y 2m
wkxyddi	Independent board member	-	Past	7y 5m
cgyfpys	Independent board member	-	Past	6y 2m

View details of Transcell's Founder profiles and Board Members

Transcell's employee count trend

Transcell has 18 employees as of May 26. Here is Transcell's employee count trend over the years:

Uncover Transcell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Transcell include Acorn, StemCyte and Cryo-Cell. Here is the list of Top 10 competitors of Transcell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Acorn 2017, Toronto (Canada), Series A	Provider of stem cell biobanking services	$3.33M	TELUS Ventures, Accelerator Centre & 5 others	55/100
2nd	StemCyte 1997, Covina (United States), Public	Cord blood banking and regenerative therapeutics company focused on saving lives	$23.3M	penbank.com, Montage Capital & 7 others	53/100
3rd	Cryo-Cell 1989, Oldsmar (United States), Public	Provider of a cord blood bank to store stem cells	$2.9M	-	47/100
4th	Transcell 2009, Hyderabad (India), Series A	Developer of stem cell therapies to treat cancer & rare diseases	$2.21M	IKP Knowledge Park, Pratithi Investments ... & 81 others	44/100
5th	Vita 34 1997, Leipzig (Germany), Public	Provider of stem cell biobanking services	-	SudBG, SHS & 1 others	42/100
6th	China Cord Blood 2003, Hong Kong (China), Acquired	Provider of biobanking services for umbilical cord blood stem cells	-	KTB Network, DCP & 7 others	41/100
7th	Forever Labs 2015, Detroit (United States), Seed	Provider of stem cell storage and preservation services	$2.22M	Launcho Ventures, UMANA House of Funds & 11 others	39/100
8th	Medeze Group 2016, Nakhon Pathom (Thailand), Public	Provider of stem cell technology and stem cell banking services	-	-	38/100
9th	LaCell 2010, New Orleans (United States), Funding Raised	Human-derived biomaterials and organ-on-a-chip models for preclinical drug development	-	National Science Foundation, HHS & 1 others	38/100
10th	Generate 1977, Los Angeles (United States), Acquired	Provider of services for the storage of stem cells	-	Longitude Capital, GI Partners	37/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Transcell's competitors? Click here to see the top ones

Founders (largest shareholder) own 39.90%, Funds own 3.06%, Enterprises own 23.79% and Angels own 30.25%. The net worth of Transcell's founders is INR 5.13Cr as of Jun 24, 2017.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	39.90%	5.13Cr	5037136	9238686	9225135	9930391
Fund	3.06%	39.3L	465	589	343	665
Enterprise	23.79%	3.06Cr	7660221	8010870	5564891	7171014
Angel	30.25%	3.89Cr	3500004	9860707	9467423	1662326
Vinayender T Tulla	106	437	909	103	417	441
Nagendra P Bandaru	26	39	64	24	46	77
Rajasekhara Rao Mukkamala	0	0	0	0	0	0
Ananda Kallugadde	0	0	0	0	0	0
Vivek Chanana	0	0	0	0	0	0
Vikas Kuthiala	0	0	0	0	0	0
Other People	3.00%	38.5L	86	73	66	57
Total	100.00%	12.9Cr	6781447	1874379	3971330	9832776